Long forms of cardiac troponin T are independent of kidney function and improve the diagnosis of myocardial infarction

Clicks: 15
ID: 332543
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #130 of 152 articles by views in nephrology dialysis transplantation

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 152 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
BACKGROUND AND HYPOTHESIS: A recently developed cardiac troponin T (cTnT) assay measuring intact or mildly fragmented cTnT (long cTnT) has shown promise in improving the accuracy of myocardial infarction (MI) detection compared to the commercial high sensitivity cTnT (hs-cTnT) assay. However, data on patients with kidney dysfunction are limited. We compared the performance of long and hs-cTnT in MI diagnostics across the full spectrum of kidney function. METHODS: In this prospective study, consecutive patients presenting at the emergency department with an elevated (≥14 ng/L) hs-cTnT were recruited. Long and hs-cTnT were measured on admission and kidney function was determined with plasma creatinine (Crea), cystatin C (CysC) and estimated glomerular filtration rate (eGFR) using contemporary equations with Crea, CysC or both (Crea-CysC) together. The association of eGFR with hs-cTnT and long cTnT concentrations and the discriminative ability of hs-cTnT and long cTnT for type 1 MI and any MI were evaluated. RESULTS: In total, 1811 patients were included, 205 (11.3%) had a MI and 204 (11.3%) had a history of chronic kidney disease. The overall median (interquartile range) Crea-eGFR, CysC-eGFR and Crea-CysC-eGFR were 71 (51-87), 52 (36-69) and 63 (44-79) ml/min/1.73m2. In patients without MI, long cTnT showed no consistent association with kidney function (β=0.0008, P = 0.050; β=0.0005, P = 0.222; β=0.0006, P = 0.182 for Crea-eGFR, CysC-eGFR and Crea-CysC-eGFR, respectively), whereas hs-cTnT was inversely associated with kidney function (β=-0.0032, -0.0035 and - 0.0035; all P < 0.001). Long cTnT demonstrated superior diagnostic performance compared with hs-cTnT for the detection of MI (P < 0.001), with the advantage becoming progressively more pronounced with lower eGFR irrespective of equation used. CONCLUSIONS: In contrast to hs-cTnT, long cTnT is unaffected by kidney function and outperforms hs-cTnT in the detection of MI, with the greatest diagnostic advantage observed in patients with lower eGFR.
Reference Key
openalex_W7222534594 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tapio Hellman, Konsta Teppo, Anna Linko-Parvinen, Hanna‐Mari Pallari, Helea Junes, T. Tuominen, Selma M Salonen, Tuomas Paana, Samuli Jaakkola, Marjatta Strandberg, Tuija Vasankari, Juhani K.E. Airaksinen, Saara Wittfooth
Are you one of these authors? Claim your profile
Journal nephrology dialysis transplantation
Year 2026
DOI
10.1093/ndt/gfag239
URL
https://doi.org/10.1093/ndt/gfag239
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.